{"_id": "64dcfe9db0d37da9c5f4af70", "nctid": "NCT03712605", "title": "STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial", "$and": [{"$and": [{"age": {"$gte": 18}}, {"ECOG status": {"$in": [0, 1, 2]}}, {"cancer stage": {"$in": ["I", "II", "IIIb"]}}, {"$not": {"$or": [{"sentinel lymph node biopsy positive": true}, {"distant metastatic disease (stage IV)": true}, {"microscopically positive margins": true}, {"distant metastatic disease of unknown primary": true}]}}, {"days since last surgery": {"$lt": 112}}, {"days since last physical exam and imaging": {"$lt": 56}}, {"no history of distant metastatic disease": true}, {"no prior systemic therapy or radiation therapy": true}, {"no completed adjuvant radiation therapy": true}]}]}